Marshall Wace, LLP Amicus Therapeutics, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 20,600 shares of FOLD stock, worth $203,734. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,600

Holding current value

$203,734

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $196,730 - $249,054	20,600 New	20,600 $220,000
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $731,702 - $860,900	62,114 New	62,114 $755,000
Q2 2021 Aug 13, 2021	BUY	$8.71 - $10.72 $147,590 - $181,650	16,945 New	16,945 $163,000
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $434,230 - $1.13 Million	-47,199 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $635,770 - $1.17 Million	47,199 New	47,199 $1.09 Million
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $5.95 Million - $9.83 Million	-742,236 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $6.28 Million - $8.25 Million	573,235 Added 339.19%	742,236 $9.26 Million
Q1 2019 May 14, 2019	BUY	$10.04 - $13.92 $109,546 - $151,881	10,911 Added 6.9%	169,001 $2.3 Million
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $8.45 Million - $13.5 Million	-1,007,851 Reduced 86.44%	158,090 $1.52 Million
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $13.5 Million - $19.3 Million	1,165,941 New	1,165,941 $14.1 Million

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$285 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$277 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$241 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$237 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$229 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.77B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account